Click here to download Preliminary List of Scientific Presentations as a pdf.

 

MOLECULAR SURVIVAL AND REGENERATION IN CARDIAC DISEASE

Pericytes for Cardiovascular Regeneration
Paolo Madeddu, University of Bristol, Bristol, UK

Enhancing Stem Cell Engraftment in the Heart Using Single Cell Microencapsulation
Dara L. Kraitchman, Johns Hopkins University, Baltimore, MD, USA

Cardioprotection by Autophagy Mediated Via Endoplasmic Reticulum Stress
Dipak K. Das, University of Connecticut School of Medicine, Farmington, CT, USA

Cardiac Tissue Hypothyroidism- A Major Player in Diabetic Cardiomyopathy
A. Martin Gerdes, New York Institute of Technology, Old Westbury, NY, USA

Thioredoxin-1 Gene Therapy for Cardiovascular Disease
Nilanjana Maulik, University of Connecticut School of Medicine, Farmington, CT, USA

DNA Topisomerase II Inhibitors Induce Macrophage ABCA1 Expression and Cholesterol Efflux-An LXR-Dependent Mechanism
Jihong Han, Nankai University, China

Failure to Overexpress Urocortin Following Cardioplegic Arrest makes the Heart of Diabetic Patients Undergoing On-pump Coronary Artery Bypass Grafting More Susceptible to Apoptosis and Cardiac Dysfunction Worsening Postsurgical Outcomes
Tiziano M. Scarabelli, Wayne State University School of Medicine, Detroit, MI, USA

PI3K Inhibitors as Novel Cancer Therapies: Implications for Cardiovascular Medicine
Gavin Y. Oudit, University of Alberta, Edmonton, AB, Canada

Protein Transduction Domains; Targeted vs. Non-Targeted Tissue Delivery
Maliha Zahid, University of Pittsburgh, Pittsburgh, PA, USA

Mechanisms of Cardiac Regeneration in Doxorubicin Induced Cardiomyopathy Following Stem Cells Transplantation
Dinender K. Singla, University of Central Florida, Orlando, FL, USA

 

VASCULAR BIOLOGY, IMMUNE MEDIATED SURVIVAL AND OXIDATIVE STRESS

mTOR Signaling in Vascular and Immune Mediated Disease
Kenneth Maiese, Mitsubishi Tanabe Pharma, Jersey City, NJ, USA

Coronary Vasomotor Regulation by Endothelin-1 and Oxidative Stress
Lih Kuo, Texas A&M Health Science Center, Temple, TX, USA

The Role of IL-10 in Cell Survival and Mitigation of Heart Failure
Pawan K. Singal, St. Boniface General Hospital Research Centre, Winnipeg, MN, Canada

The Role of Nitric Oxide/Peroxynitrite Imbalance in the Ischemic Heart
Tadeusz Malinski, Ohio University, Athens, OH, USA

A Novel Role of Endothelial Dihydrofolate Reductase in Cardiovascular Pathophysiology
Hua Linda Cai, UCLA David Geffen School of Medicine Los Angeles, CA, USA

Hypercholesterolemia-Induced Oxidative Stress in the Heart
Kailash Prasad, University of Saskatchewan, Saskatoon, SK, Canada

Role of Cross-Talk between NADPH Oxidase and Mitochondria for Regulating VEGF Signaling and Angiogenesis
Masuko Ushio-Fukai, University of Illinois at Chicago, Chicago, IL, USA

Statin Effects beyond Lipid Lowering: Atorvastatin Inhibition of Myocardin Expression in Vascular Smooth Muscle
Xi-Long Zheng, University of Calgary, Calgary, AB, Canada

 

INFLAMMATION / INNATE AND ADOPTIVE IMMUNITY AND CARDIOVASCULAR DISEASES

Inflammation - The New Target for Prevention of Coronary Artery Disease
Robert Roberts, University of Ottawa Heart Institute, Ottawa, ON, Canada

Sepsis and the Cardiovascular System: Going to the Heart of the Matter
Marcos A. Rossi, University of Sao Paulo. Brazil

Neutrophils in Acute Coronary Artery Disease
Janos G. Filep, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada

Interaction of Gene and Salt Diets on Cardiac Angiotensin II, Aldosterone, and Cytokines in Hypertrophied Heart
Kailash N. Pandey, Tulane University School of Medicine, New Orleans, LA, USA

Microbiota, Systemic Inflammation and Cardiovascular Function
Mohamad Navab, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA 

Role of Copper Transporters in Vascular Remodeling and Inflammation
Tohru Fukai, University of Illinois at Chicago, Chicago, IL, USA

The Complex Cardiovascular Effects of Leptin
Matthew A. Allison, University of California, San Diego, La Jolla, CA, USA

Human Enterovirus Persistence: Potential for Exacerbation of Viral Inflammatory Heart Disease
Nora M. Chapman, University of Nebraska Medical Center, Omaha, NE, USA

The Citokines and the Role of Immunomodulation in Heart Failure
Sergio Dalla-Volta, Universita degli Studi di Padova, Padova, Italy

 

CARDIOVASCULAR IMAGING MODALITIES FOR EVALUATION OF CORONARY CIRCULATION, CARDIAC STRUCTURE AND FUNCTION

Newer Aspects of Evaluating LV Function by Echocardiograph
Navin C. Nanda, University of Alabama at Birmingham, Birmingham, AL, USA

Flurpiridaz F 18 PET Versus TC-99m SPECT For Myocardial Perfusion Imaging
D.S. Berman, Cedars-Sinai Medical Center; Los Angeles, California, USA

Usefulness of Optical Coherence Tomography in Daily Clinical Practice
Takashi Akasaka, Wakayama Medical University, Wakayama, Japan

Myocardial Strain for the Assessment of LV Function
Sherif F. Nagueh, Methodist DeBakey Heart and Vascular Center, Houston, TX, USA

Screening for Asymptomatic Coronary Artery Disease: Seeking Value in a Multi-Modality World
J.J. Mahmarian, Methodist DeBakey Heart & Vascular Center, The Methodist Hospital, Houston, TX, USA

Myocardial Viability and Outcomes in Ischemic Cardiomyopathy
Jamshid Shirani, St. Luke’s Hospital and Health Network, Bethlehem, PA, USA

Novel Uses of Cardiac MRI for Non-Ischemic Heart Disease
Robert W.W. Biederman, Temple University School of Medicine, Carnegie Mellon University, Allegheny General Hospital, Pittsburgh, PA, USA

Prognostic Value of Stress Echocardiography in Patients with Coronary Artery Disease
Maria Prokudina, Federal Center of Heart, Blood and Endocrinology, St. Petersburg, Russia

Non-invasive Cardiovascular Imaging for Evaluation of Coronary Artery Bypass Graft Disease                                          
Abdou Elhendy, Marshfield Clinic, Marshfield, WI, USA

Optical Coherence Tomography. What you need to know
Joel A. Garcia, Denver Health Medical Center (DHMC) and University of Colorado Hospital at Denver, Denver, CO, USA

New Insights on Myocardial and Arterial Viscoelasticity and Stiffness Measured In Vivo by New Shear Wave Methods
Cristina Pislaru, Mayo Clinic College of Medicine, Rochester, MN, USA

 

DISEASE MECHANISMS LEADING TO CARDIOMYOPATHY AND HEART FAILURE

Advances in Pathophysiology and Management of Diastolic Heart Failure
Kanu Chatterjee, University of Iowa, IA, USA

Reversal of Cardiac Remodeling in Heart Failure by α-Adrenoceptor Blockade
Naranjan S. Dhalla, St. Boniface General Hospital Research Centre, Winnipeg, MN, Canada

Aging and Heart Failure. Update
Bodh I. Jugdutt, University of Alberta and Hospitals, Edmonton, AB, Canada

Mitochondrial Fission and Fusion in Heart Failure
Anne A. Knowlton, University of California, Davis, CA, USA

Personalized Medicine in Dilated Cardiomyopathy
Luisa Mestroni, University of Colorado Cardiovascular Institute, Aurora, CO, USA

Genetic Epidemiology of Left Ventricular Hypertrophy
Jonathan N. Bella, Bronx-Lebanon Hospital Center, Bronx, NY, USA

Blunted Responses of Renal Sympathetic Nerve Activity to C-Type Natriuretic Peptide in the PVN of Rats with Heart Failure
Kaushik P. Patel, University of Nebraska Medical Center, Omaha, NE, USA

CPT1b Deficiency Is Bad For the Hypertrophied Heart
Qinglin Yang, University of Alabama at Birmingham, Birmingham, AL, USA

Deletion of the Translational Repressors Eukaryotic Translation Initiation Factor 4E Binding Proteins 1 And 2 Protects Against Pressure Overload Induced Heart Failure
Yingjie Chen, University of Minnesota, MN, USA

Residual Myocardial Injury and Attenuated Production of Vascular Endothelial Growth Factor (VEGF) in Patients with Recovered Peripartum Cardiomyopathy (PPCM)  
Sorel Goland, Kaplan Medical Center, Rehovot, Israel

Cardiac Fibroblasts: Friend or Foe in Cardiac Remodeling?
Burns C. Blaxall, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA

 

ADVANCES IN THE TREATMENT AND MANAGEMENT OF HEART FAILURE

Circulating microRNAs as Biomarkers in Heart Failure: Outcomes of the First Large Studies
Yigal Pinto, Heart Centre at the University of Amsterdam, Amsterdam, The Netherlands

New Therapies for Diastolic Heart Failure
Samuel C. Dudley, University of Illinois at Chicago, Chicago, IL, USA

Partial Adenosine A1-Receptor Agonists for the Treatment of Heart Failure
Hani N. Sabbah, Henry Ford Heart & Vascular Institute, Detroit, MI, USA

Enhancing Glucose Oxidation as an Approach to Treat Heart Failure
Gary Lopaschuk, University of Alberta, Edmonton, AB, Canada

The Management of Patients with Advanced Heart Failure
Maria Vittoria H. Pitzalis Zapler, East Carolina University, Greenville, NC, USA

Ultrafiltration in the Treatment of Volume Overload Due to Heart Failure
Uri Elkayam, University of Southern California, Keck School of Medicine, Los Angeles, CA, USA

Role of Peritoneal Dialysis in Management of Heart Failure: an Update for 2013
Amir Kazory, University of Florida, Gainesville, FL, USA

Biomarker Solutions for Heart Failure and COPD Management
Bruce M. McManus, St. Paul's Hospital, Vancouver, BC, Canada

Benefit of Heart Rate Reduction in Ischemic Heart Disease and Heart Failure
Giuseppe M.C. Rosano, IRCCS San Raffaele, Rome, Italy

Predominant Differential Cause of Dyspnea in Atrial Fibrillation and Coincident COPD. Inflammation, Latent Ischemia and Myocardial Dysfunction, Thrombogenesis, Apoptosis and Cardiovascular Remodeling or Respiratory Impairment?
Nestor J. Angomachalelis, Aristotle University, School of Medicine, Thessaloniki, Macedonia, Greece

Efficacy and Safety of Ivabradin in Patients with Idiopathic Dilated Cardiomyopathy
Shorena Chumburidze, Scientific Research Clinic of Therapy, Tbilisi, Rep. of Georgia

 

SUDDEN CARDIAC DEATH / ADVANCES IN IMPLANTABLE RHYTHM DEVICE THERAPY

Impact of Denervated Myocardium on Improving Risk Stratification for Sudden Cardiac Death
Michael E. Cain, University at Buffalo, Buffalo, NY USA

Catheter Ablation in Patients with Electrical Storm - Benefit of a Clinical Network
Thomas Deneke, University of Bochum, Bochum, Germany

The Role of Electrophysiologic Testing on Outcome in Patients with ARVC
Firat Duru, University Hospital of Zurich, Switzerland

Robotics in the EP Laboratory: Promise, Reality and Future Directions
Eli Gang, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

Biventricular versus Right Ventricular Pacing in Patients with Left Ventricular Dysfunction and Atrioventricular Block: The Block HF Study
Anne B. Curtis, University at Buffalo, Buffalo, NY, USA

Limitations of Resynchronization Therapy in Patients with Narrow QRS: Insights from the EARTH Trial
Bernard Thibault, Montreal Heart Institute, Montreal, Canada

In the OR v. The EP Lab--Where Is the Best Location for Lead Extraction
Charles Henrikson, Oregon Health & Science University, Portland, OR, USA

Catecholaminergic Polymorphic Ventricular Tachycardia - The Clinician's Perspective
Martin J. LaPage, University of Michigan, Ann Arbor, MI, USA

Genetic Background, Clinical Characteristics, and Treatment of Early Repolarization Syndrome
Hiroshi Watanabe, Niigata University Graduate School of Medical & Dental, Asahimachidori, Niigata, Japan

The Evolution of the Pacing Site: Past, Present and Future
Yasushi Oginosawa, University of Occupational and Environmental Health, Yahatanishi, Kitakyushu, Japan

 

ARRHYTHMIA, ELECTROPHYSIOLOGY AND STROKE PREVENTION

The Work Up of Asymptomatic Wolff-Parkinson-White Syndrome
Christopher S. Snyder, Rainbow Babies and Children's Hospital, Cleveland, OH, USA

Atrial Fibrillation as a Genetic Disease
Michael H. Gollob, University of Ottawa Heart Institute, Ottawa, Ontario, Canada

Is there a Perfect Approach for Ablation Persistent Atrial Fibrillation?
Komandoor Srivathsan, Mayo Clinic, Arizona, AZ, USA

Thoracoscopic Biatrial Maze Procedure – A Novel Minimal-Invasive Remedy with Promising Midterm Results
Ali Khoynezhad, Cedars-Sinai Medical Center, Los Angeles, CA, USA

Left Atrial Appendage Closure
Stefan Bertog, CVC Frankfurt/Minneapolis VA Medical Center, MN, USA

New Anticoagulants in AF Therapy: What Benefits the Patient Most?
Alessandro Capucci, Universita Politecnicadelle Marche, Ancona, Italy

Anticoagulation in Patients with Systolic Heart Failure and Sinus Rhythm: When?
Ertan Yetkin, Middle East Hospital, Mercin, Turkey

Cryptogenic Stroke - Could Long Term Cardiac Monitoring Uncover the Cause
J. Rod Gimbel, Knoxville, TN, USA

My Patient Cannot Stand Up: What to do about Orthostatic Hypotension
Satish R. Raj, Vanderbilt University, Nashville TN, USA

 

THE KIDNEY, BLOOD PRESSURE AND HYPERTENSION MANAGEMENT

Optimal Blood Pressure Goals in Patients at High Risk for Cardiovascular Events
Wilbert S. Aronow, New York Medical College, Valhalla, NY, USA

Dual RAAS Blockade: Too much of a Good Thing?
Alexander H. Danser, Erasmus Medical Center, Rotterdam, The Netherlands

Novel Technologies to Manage Blood Pressure in Patients with Autonomic Dysfunction
Andre Diedrich, Vanderbilt University School of Medicine, Nashville, TN, USA

Natriuretic Peptide Receptor-C, Gi Proteins and Regulation of Blood Pressure
Madhu B. Anand-Srivastava, University of Montreal, Montreal, QC, Canada

Role of Ingestion-Time of Renin-Angiotensin Blockade for Reducing Blood Pressure and Cardiovascular Risk
Ramon C. Hermida, Campus Universitario Vigo, Pontevedra, Spain

Renal Denervation in Hypertension and More?
Felix Mahfoud, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany

Use of Ambulatory Blood Pressure Monitor (ABPM) for Guiding Cardiac Patients Management 
Yzhar Charuzi, UCLA School of Medicine, CA, USA

Chronotherapy with Low-Dose Aspirin for Prevention of Complications in Pregnancy
Diana E. Ayala, Campus Universitario, Vigo, Spain

 

CAN WE BUILD A BETTER MODEL:  CVD RISK PREDICTION

Coronary Artery Calcium Density and Cardiovascular Events
Michael H. Criqui, University of California, San Diego, La Jolla, CA,USA

Carotid Ultrasound Evaluation of Subclinical Atherosclerosis in 2013: Progress and Pitfalls
Julius M. Gardin, Hackensack University Medical Center, Hackensack, NJ, USA

Is Diabetes Really a Coronary Heart Disease Risk Equivalent?
Nathan D. Wong, University of California, Irvine. CA, USA

Risk Factors for Cardiovascular Disease in Patients with Chronic Kidney Disease
Martin Alpert, University of Missouri-Columbia, Columbia, MO, USA

The High Coronary Disease Risk of South Asian Americans
Arthur L. Klatsky, Kaiser Permanente Medical Center, Oakland, CA, USA

Psychosocial Risks and Mental Stress Induced Myocardial Ischemia in Patients with Ischemic Heart Disease
Wei Jiang, Duke University Medical Center, Durham, NC, USA

Bidirectional Risks of CardioVascular Disease and Cognitive Impairment
Kannayiram Alagiakrishnan, University of Alberta, Edmonton, Alberta, Canada

Are Gender Differences in Heart Disease more Significant than the Similarities?
Shaista Malik, UC Irvine, CA, USA

Lipoprotein-associated Phospholipase A2 as a Novel Risk Marker for Cardiovascular Disease and a Potential Target for Therapy
Mohammad Madjid, Texas Heart Institute, Houston, TX, USA

 

PREVENTION OF CARDIOVASCULAR DISEASE: ASSESSMENT AND MANAGEMENT OF CARDIOVASCULAR RISK

Gender Differences in Cardiovascular Medicine
Vera Regitz-Zagrosek, Center for Cardiovascular Research (CCR) Coordinator Berlin, German 

The Association between Depression and Diabetes
Elizabeth Barrett-Connor, UCSD Dept. of Family and Preventive Medicine, La Jolla, CA, USA

Aldosterone - A Bridge Between Cardiovascular and Mood Disorders?
Daniela Jezova, Slovak Academy of Sciences, Bratislava, Slovak Republic

HDL and the Atherosclerosis - Myth or Reality
Robert S. Rosenson, Mount Sinai Heart Mount Sinai School of Medicine, New York, NY, USA

Omega-3 Supplementation Improves Arterial Stiffness and Biomarkers of CV Risk in Latino and White Patients with Hypertension Served By a Safety-Net Healthcare System
Carlin S. Long, University of Colorado Health Sciences Center and Denver Health Medical Center, Denver, CO, USA

Impact of Renal Sympathetic Denervation in Patients with Drug Resistant Hypertension
Karlheinz Seidl, Klinikum Ingolstadt GmbH, Ingolstadt, Germany

How much of the CVD Risk is attributed to Diet?
Demosthenes B. Panagiotakos, Harokopio University of Athens, Athens, Greece

Beyond HDL Cholesterol: What Can We Learn from HDL Particle Number and Size?
Samia Mora, Brigham and Women’s Hospital, Boston, MA, USA

Dysfunctional HDL - Novel Biomarker of Lipid Disorders?
Maciej Banach, Medical University of Lodz, Poland

Sex Matters: Differences in Associations between Risk Factors and Cardiovascular Disease
Rachel Huxley, University of Minnesota School of Public Health, Minneapolis, MN, USA

 

STABLE ISCHEMIC HEART DISEASE – THERAPEUTIC OPTIONS

Women and Heart Disease: A Fresh Perspective
Ezra A. Amsterdam, University of California, Davis Medical Center, Sacramento, CA, USA

Impact of Life Style Modifications, Antianginals, Antiplatelets and Lipid Modifying Drugs and of Coronary Artery Revascularization on Mortality and Morbidity in Patients with Ischemic Heart Disease: Truth and False Notions
Udho Thadani, University of Oklahoma HSC and VA Medical Center, Oklahoma City, OK, USA

Integrative Therapy in Cardiovascular Disease: Savior or Sham?
Saul Schaefer, University of California, Davis, CA, USA

Medical Risk Factor Control in Large Trials of Diabetic Patients Undergoing Coronary Revascularization
Michael E. Farkouh, University of Toronto, Toronto, Ontario, Canada

PTEN and Statins Induced New Onset Diabetes
Yochai Birnbaum, Baylor College of Medicine, Houston, TX, USA

Anti-Atherosclerotic Effects of Incretin Based Therapies
Ishwarlal Jialal, UC Davis Medical Center, Sacramento, CA USA

Advances in the Treatment of Coronary Artery Disease in the Elderly
Issam Mikati, Northwestern Memorial Hospital, Chicago, IL, USA

Is There a Role for Coronary Artery Calcium (CAC) Testing in Symptomatic Patients in the Era of Coronary CT Angiography?
Khurram Nasir, Baptist Health South Florida, Johns Hopkins Ciccarone Center for Preventive Cardiology, Miami, FL, USA

A New Strategy for Discontinuation of Dual Antiplatelet Therapy:  The RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)
Myeong-Ki Hong, Severance Cardiovascular Center and Severance Biomedical Science Institute, Seoul, Korea

 

CURRENT CONCEPTS AND FUTURE DIRECTIONS IN ISCHEMIC HEART DISEASE AND ACUTE CORONARY SYNDROMES

Why ACS Occurs and How We Can Prevent It
Yasunori Ueda, Osaka Police Hospital, Tennoj-ku, Osaka, Japan

High Sensitivity Troponins: A Step Forward or an Unrequested Complication?
Luigi M. Biasucci, Policlinico A. Gemelli, Catholic University of the Sacred Heart Largo, Rome, Italy

The Complicated STEMI: What to Do With Multivessel Disease
Gregory W. Barsness, Mayo Clinic, Rochester, MN, USA

Embolic protection in STEMI
Edo Kaluski, University Hospital, Newark, NJ, USA

Femoral or Radial Access for Primary PCI: A Dilemma of Choice
Asim N. Cheema, St. Michael's Hospital, Toronto, ON, Canada

Trends in Management and Outcome of Hospitalized Patients with Acute Coronary Syndromes in the Last Decade: The ACS Israeli Survey (ACSIS) Experience
Shmuel Gottlieb, Jerusalem, Israel

Recurrent Versus First, ST-Elevation versus Non-ST-Elevation Myocardial Infarction: Results from national Israel surveys ACSIS 2000-2010
Avraham Shotan, Hillel Yaffe Medical Center, Hadera, Israel

Prevention of Reperfusion Injury in Patients with ST Elevation Myocardial Infarction: The cGMP Pathway
David Garcia-Dorado, Vall d'Hebron University Hospital and Research Institute Universitat Autònoma de Barcelona, Barcelona, Spain

Protective Effect of Telmisartan against Endothelial Dysfunction after Coronary Drug-Eluting Stent Implantation in Hypertensive Patients
Mitsuyasu Terashima, Toyohashi Heart Center, Toyohashi, Japan

New Insights into Spontaneous Coronary Artery Dissection
Rajiv Gulati, Mayo Clinic, Rochester, MN, USA

 

PATHOGENESIS, DIAGNOSIS AND TREATMENT OF AORTIC ANEURYSMS AND PERIPHERAL ARTERY DISEASE

Practical Genetics of Thoracic Aortic Aneurysm
J.A. Elefteriades, Aortic Institute at Yale-New Haven, New Haven, CT, USA

Update on AHA Guidelines for Management of Thoracic Aortic Disease
Angela T. Yetman, University of Utah, Salt Lake City, UT, USA

Lessons from Animal Models of Arterial Aneurysm
S. David Gertz, The Hebrew University - Hadassah Medical School, Jerusalem, Israel

Polyvascular Disease: Diagnosis and Treatment
Takanobu Tomaru, Toho University Sakura Hospital, Japan

Ige Activities on CD4+ T Cells Are Equally Important To Those on Mast Cells in Experimental Abdominal Aortic Aneurysms
Guo-Ping Shi, Brigham and Women's Hospital, Boston, MA, USA

Drug Eluting Balloons and Stents for Endovascular Treatment of Peripheral Arterial Disease
Subhash Banerjee, VA North Texas Healthcare System, Dallas, TX, USA

The Multilayer Flow Modulator Stent (MFM) For the Treatment of Aortic Aneurysms
Michel Henry, Nancy, France

 

VALVULAR HEART DISEASE: MECHANISMS, IMAGING AND TREATMENT OPTIONS (I)

Anticoagulation and Heart Valve Disease: Is it Time to Reconsider Who and How?
Jeffrey S. Borer, State University of New York Downstate Medical Center, New York, NY, USA

New Insight into Treatment of Aortic Stenosis: Light at the End of the Tunnel
Donald D. Heistad, University of Iowa College of Medicine, Iowa City, IA, USA

Oxidative-Mechanical Signaling Activates Wnt3a-Lrp5 Mediated Aortic Valve Osteogenesis in Bicuspid Aortic Valve Disease
Nalini M. Rajamannan, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Transapical Transcatheter Aortic Valve Replacement in the Presence of a Mitral Prosthesis
Jian Ye, University of British Columbia, Vancouver, BC, Canada

Evolving Treatment Strategies for Tricuspid Valve Disease
Hanumanth Reddy, University of Arkansas for Medical Sciences, Little Rock, AR, USA

TAVI: Wave of the Future or Time for a Deep Breath?
Harold L. Lazar, Boston Medical Center, Boston, MA, USA

Echocardiography for TAVR
Stamatios Lerakis, Emory University Hospital, Atlanta, GA, USA

Asymptomatic Severe Aortic Stenosis: Operate or Wait?
Hari P. Chaliki, Mayo Clinic, Scottsdale, AZ, USA

Early Surgery in Mitral Regurgitation: Is it a New Trend?
Yong-Jin Kim, Seoul National University College of Medicine, Chongno-gu, Seoul, Korea

Major Non-cardiac Surgery in Patients with Aortic Stenosis - Same as 20 years ago?
Sorin Pislaru, Mayo Clinic College of Medicine, Rochester, MN, USA

Surgical Timing for Infective Endocarditis
Duk-Hyun Kang, University of Ulsan, Asan Medical Center, Seoul, Korea

 

ADVANCES IN CARDIOVASCULAR SURGERY, HEART TRANSPLANTATION, CAROTID AND CORONARY REVASCULARIZATION

Changes in Heart Allocation for Transplantation in the US and Worldwide: Options for a Better Solution
Dan M. Meyer, University of Texas Southwestern, Med Center at Dallas, Dallas, TX, USA

Simultaneous Heart-Kidney Transplantation
Maryl R. Johnson, University of Wisconsin-Madison, Madison, WI, USA

Where is the Fine Balance between Immune suppression and Malignancy in Cardiac Transplantation?
Nandini Nair, Texas A&M HSC College of Medicine, Temple, TX, USA

Assist device in the Elderly
Roland Hetzer, German Heart Institute, Berlin, Germany

Update on the Use of Impella Assist Device for High Risk Patients Undergoing Percutaneous Coronary Interventions
Mohammad-Reza Movahed, University of Arizona Sarver Heart Center, Tucson, AZ, USA

New Strategies for Acute Stroke Intervention
Horst Sievert, CardioVascular Center Frankfurt, Frankfurt, Germany

Device Closure of ASD- Long-Term Follow Up with Special Reference to Complications
Masood Sadiq, The Children’s Hospital, Punjab Institute of Cardiology, Lahore, Pakistan

Update on the Treatment of Left Main Disease
Barry F. Uretsky, University of Arkansas for Medical Sciences, Little Rock, AR, USA

California Revascularization: PCI and CABG outcomes in the Sunshine State
William Bommer, University of California Davis, Medical Center, Davis, CA, USA

Management Strategies of Combined Severe Symptomatic Carotid and Coronary Artery Disease
Mazen Abu-Fadel, University of Oklahoma HScC, Oklahoma City, OK, USA